Dupilumab in Adults with Moderate-To-Severe Atopic Dermatitis and Prior Use of Systemic Non-Steroidal-Immunosuppressants: Analysis of Four Phase 3 Trials
posted on 2021-06-15, 13:36authored byAdis journals on behalf of:, Christopher Griffiths, Marjolein de Bruin-Weller, Mette Deleuran, Maria Concetta Fargnoli, Delphine Staumont-Sallé, Chih-ho Hong, Jose Sánchez-Carazo, Peter Foley, Seong Jun Seo, Jérôme Msihid, Zhen Chen, Sonya L. Cyr, Ana B. Rossi
Article full
text
The above video and graphical abstract represents
the opinions of the authors. For a full list of declarations, including funding
and author disclosure statements, please see the full text online (see “read
the peer-reviewed publication” opposite).